Alnylam Pharmaceuticals
ALNY
#548
Rank
A$64.32 B
Marketcap
A$486.89
Share price
0.31%
Change (1 day)
8.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company